Yu-Hao XueYu-Shin PengHsin-Fu TingJason Peijer HsiehYu-Kai HuangYu-Hsun WangJeng-Yuan ChiouJames Cheng-Chung Wei2026-01-292026-01-29201810.1159/000485176https://scholars.csmu.edu.tw/handle/123456789/3725<jats:p>&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; This population-based cohort study investigates the association between osteoarthritis (OA) and dementia as well as the connection between NSAIDs and dementia. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; We chose the samples from the Taiwan Longitudinal Health Insurance Database and then divided them into two groups, which were then matched 1: 1 by propensity score. The first group was the OA group that contained patients with newly diagnosed OA and the second group was the non-OA group. We used the χ&lt;sup&gt;2&lt;/sup&gt; test, Student &lt;i&gt;t&lt;/i&gt; test, Kaplan-Meier analysis, and Cox proportional hazard model for different purposes. &lt;b&gt;&lt;i&gt;Results:&lt;/i&gt;&lt;/b&gt; The prevalence of dementia in the OA group was higher than that in the non-OA group. The adjusted hazard ratio of the former was 1.42 (95% CI, 1.30–1.54). We also found that etoricoxib and diclofenac might reduce the incidence of dementia. &lt;b&gt;&lt;i&gt;Conclusion:&lt;/i&gt;&lt;/b&gt; Patients with OA might have a higher risk of dementia. Both etoricoxib and diclofenac might lower the risk of dementia in patients with OA.</jats:p>[SDGs]SDG3Etoricoxib and Diclofenac Might Reduce the Risk of Dementia in Patients with Osteoarthritis: A Nation-Wide, Population-Based Retrospective Cohort Studyjournal-article